Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oncolytic Virotherapy | 11 | 2023 | 280 | 5.080 |
Why?
|
Adenoviridae | 16 | 2023 | 1459 | 4.100 |
Why?
|
Oncolytic Viruses | 8 | 2023 | 204 | 3.770 |
Why?
|
Genetic Vectors | 15 | 2020 | 1694 | 2.280 |
Why?
|
Transgenes | 9 | 2015 | 557 | 1.610 |
Why?
|
Immunotherapy, Adoptive | 6 | 2023 | 1763 | 1.580 |
Why?
|
Genetic Therapy | 10 | 2023 | 1616 | 1.360 |
Why?
|
Interleukin-12 | 4 | 2021 | 253 | 1.140 |
Why?
|
Helper Viruses | 5 | 2021 | 55 | 1.120 |
Why?
|
Sarcoidosis | 2 | 2022 | 112 | 0.930 |
Why?
|
Simplexvirus | 3 | 2009 | 159 | 0.920 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2015 | 155 | 0.820 |
Why?
|
Janus Kinases | 1 | 2023 | 174 | 0.810 |
Why?
|
Immunity, Innate | 5 | 2023 | 677 | 0.800 |
Why?
|
Receptors, Antigen, T-Cell | 5 | 2021 | 1146 | 0.730 |
Why?
|
Ecosystem | 1 | 2021 | 111 | 0.720 |
Why?
|
Myocarditis | 1 | 2022 | 190 | 0.710 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 476 | 0.680 |
Why?
|
Neoplasms | 6 | 2023 | 15193 | 0.670 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2020 | 202 | 0.660 |
Why?
|
Dependovirus | 4 | 2021 | 135 | 0.650 |
Why?
|
Amino Acids | 1 | 2021 | 728 | 0.620 |
Why?
|
B7-H1 Antigen | 4 | 2021 | 1022 | 0.600 |
Why?
|
Antibodies, Bispecific | 1 | 2020 | 246 | 0.560 |
Why?
|
Adoptive Transfer | 1 | 2018 | 446 | 0.550 |
Why?
|
Recombinant Fusion Proteins | 3 | 2017 | 1555 | 0.530 |
Why?
|
Aorta, Thoracic | 1 | 2020 | 546 | 0.520 |
Why?
|
Gene Silencing | 2 | 2010 | 837 | 0.510 |
Why?
|
T-Lymphocytes | 4 | 2023 | 3869 | 0.480 |
Why?
|
Factor X | 1 | 2012 | 10 | 0.450 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2021 | 3821 | 0.420 |
Why?
|
Antibodies, Monoclonal | 3 | 2021 | 4367 | 0.410 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2011 | 25 | 0.400 |
Why?
|
Interferon Type I | 1 | 2013 | 250 | 0.400 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8865 | 0.370 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2341 | 0.370 |
Why?
|
Animals | 24 | 2023 | 59536 | 0.360 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2021 | 1724 | 0.360 |
Why?
|
Herpesvirus 1, Human | 2 | 2008 | 113 | 0.340 |
Why?
|
Gene Expression | 5 | 2017 | 3570 | 0.340 |
Why?
|
Gene Transfer Techniques | 5 | 2021 | 716 | 0.340 |
Why?
|
Mice | 20 | 2023 | 34495 | 0.340 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 107 | 0.320 |
Why?
|
Chromatin Immunoprecipitation | 4 | 2013 | 518 | 0.320 |
Why?
|
Aortic Valve | 3 | 2021 | 581 | 0.320 |
Why?
|
Receptor, ErbB-2 | 5 | 2021 | 2518 | 0.320 |
Why?
|
Liver | 6 | 2015 | 2961 | 0.300 |
Why?
|
Heart Failure | 1 | 2021 | 2516 | 0.300 |
Why?
|
Transduction, Genetic | 4 | 2016 | 475 | 0.300 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 598 | 0.290 |
Why?
|
STAT1 Transcription Factor | 1 | 2007 | 156 | 0.290 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 5437 | 0.280 |
Why?
|
Chromatin | 3 | 2023 | 942 | 0.280 |
Why?
|
Head and Neck Neoplasms | 2 | 2021 | 3976 | 0.280 |
Why?
|
Clinical Studies as Topic | 2 | 2021 | 19 | 0.240 |
Why?
|
Plasmids | 1 | 2006 | 837 | 0.240 |
Why?
|
Liver Abscess | 1 | 2023 | 36 | 0.240 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2009 | 854 | 0.230 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5061 | 0.230 |
Why?
|
Humans | 28 | 2023 | 261506 | 0.230 |
Why?
|
Tumor Burden | 2 | 2021 | 1987 | 0.230 |
Why?
|
Toll-Like Receptor 9 | 2 | 2015 | 78 | 0.220 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 14551 | 0.220 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 2864 | 0.220 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 79 | 0.220 |
Why?
|
Blastocyst | 1 | 2023 | 124 | 0.220 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 6942 | 0.210 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2022 | 121 | 0.210 |
Why?
|
Mice, Knockout | 8 | 2015 | 5710 | 0.200 |
Why?
|
Cytokines | 3 | 2023 | 2809 | 0.200 |
Why?
|
Adaptive Immunity | 2 | 2015 | 149 | 0.200 |
Why?
|
Mitral Valve Prolapse | 1 | 2021 | 17 | 0.200 |
Why?
|
Escherichia coli Infections | 1 | 2023 | 241 | 0.200 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2022 | 88 | 0.200 |
Why?
|
A549 Cells | 2 | 2021 | 124 | 0.190 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 305 | 0.190 |
Why?
|
Single-Chain Antibodies | 1 | 2021 | 62 | 0.190 |
Why?
|
Viral Tropism | 2 | 2021 | 40 | 0.190 |
Why?
|
Immunoglobulin A | 1 | 2021 | 237 | 0.180 |
Why?
|
Male | 12 | 2022 | 123000 | 0.180 |
Why?
|
Accessory Atrioventricular Bundle | 1 | 2019 | 7 | 0.180 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 160 | 0.180 |
Why?
|
Dysbiosis | 1 | 2021 | 134 | 0.180 |
Why?
|
Signal Transduction | 2 | 2023 | 11965 | 0.170 |
Why?
|
Coculture Techniques | 1 | 2021 | 626 | 0.170 |
Why?
|
Sinus of Valsalva | 1 | 2020 | 53 | 0.170 |
Why?
|
Female | 12 | 2023 | 141928 | 0.170 |
Why?
|
Mammals | 1 | 2021 | 361 | 0.170 |
Why?
|
Transcription, Genetic | 1 | 2007 | 3154 | 0.170 |
Why?
|
Hyaluronan Receptors | 1 | 2020 | 249 | 0.170 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 180 | 0.170 |
Why?
|
Histone Deacetylases | 2 | 2013 | 365 | 0.170 |
Why?
|
Interferon-alpha | 1 | 2023 | 889 | 0.160 |
Why?
|
Computed Tomography Angiography | 1 | 2020 | 234 | 0.160 |
Why?
|
Inflammation | 2 | 2022 | 2522 | 0.150 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 905 | 0.150 |
Why?
|
Crime | 1 | 2017 | 31 | 0.150 |
Why?
|
Coronary Angiography | 1 | 2020 | 598 | 0.150 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2021 | 314 | 0.150 |
Why?
|
Hep G2 Cells | 1 | 2017 | 155 | 0.150 |
Why?
|
Fibroblasts | 3 | 2010 | 1682 | 0.140 |
Why?
|
Lymphocyte Transfusion | 1 | 2017 | 175 | 0.140 |
Why?
|
Retrospective Studies | 5 | 2022 | 37905 | 0.140 |
Why?
|
Antibody Formation | 2 | 2015 | 383 | 0.140 |
Why?
|
Antibodies, Neoplasm | 1 | 2017 | 259 | 0.140 |
Why?
|
Bacteria | 1 | 2021 | 611 | 0.140 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 1301 | 0.140 |
Why?
|
Intestines | 1 | 2021 | 686 | 0.140 |
Why?
|
DNA Primers | 2 | 2009 | 1399 | 0.140 |
Why?
|
Mice, Nude | 3 | 2017 | 4307 | 0.140 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 1226 | 0.140 |
Why?
|
DNA, Viral | 2 | 2009 | 694 | 0.130 |
Why?
|
Histones | 1 | 2023 | 1466 | 0.130 |
Why?
|
Mice, SCID | 1 | 2020 | 1869 | 0.130 |
Why?
|
Serpins | 1 | 2015 | 77 | 0.130 |
Why?
|
ErbB Receptors | 1 | 2004 | 2295 | 0.130 |
Why?
|
Nerve Growth Factors | 1 | 2015 | 109 | 0.130 |
Why?
|
Heart | 1 | 2022 | 1223 | 0.130 |
Why?
|
RNA, Messenger | 3 | 2011 | 6150 | 0.130 |
Why?
|
Brain | 1 | 2008 | 4113 | 0.130 |
Why?
|
Factor VIII | 2 | 2012 | 75 | 0.120 |
Why?
|
Eye Proteins | 1 | 2015 | 269 | 0.120 |
Why?
|
Osteogenesis Imperfecta | 1 | 2015 | 140 | 0.120 |
Why?
|
Heart Diseases | 1 | 2020 | 732 | 0.110 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 4971 | 0.110 |
Why?
|
Myocardium | 1 | 2020 | 1313 | 0.110 |
Why?
|
Promyelocytic Leukemia Protein | 1 | 2013 | 55 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2017 | 541 | 0.110 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 2173 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 3639 | 0.110 |
Why?
|
Capsid | 1 | 2012 | 103 | 0.110 |
Why?
|
Bone and Bones | 1 | 2015 | 619 | 0.110 |
Why?
|
Base Sequence | 2 | 2009 | 4917 | 0.100 |
Why?
|
Tomography | 2 | 2022 | 55 | 0.100 |
Why?
|
Hemophilia A | 1 | 2011 | 25 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2021 | 32848 | 0.100 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 5112 | 0.090 |
Why?
|
Genome, Viral | 1 | 2011 | 155 | 0.090 |
Why?
|
Cell Line | 2 | 2010 | 5114 | 0.090 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 87 | 0.090 |
Why?
|
Epigenomics | 1 | 2011 | 266 | 0.090 |
Why?
|
Aged | 5 | 2022 | 70117 | 0.090 |
Why?
|
beta-Galactosidase | 1 | 2010 | 211 | 0.090 |
Why?
|
Interleukin-10 | 1 | 2012 | 478 | 0.090 |
Why?
|
Genes, Reporter | 2 | 2015 | 798 | 0.090 |
Why?
|
Histone Deacetylase 1 | 1 | 2009 | 62 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 284 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 7551 | 0.080 |
Why?
|
Th1 Cells | 1 | 2010 | 250 | 0.080 |
Why?
|
Corpus Striatum | 1 | 2008 | 104 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2012 | 649 | 0.080 |
Why?
|
Interferon-beta | 1 | 2008 | 102 | 0.080 |
Why?
|
Spleen | 1 | 2010 | 676 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2022 | 29902 | 0.080 |
Why?
|
Aorta | 2 | 2022 | 692 | 0.080 |
Why?
|
CD11b Antigen | 1 | 2007 | 66 | 0.080 |
Why?
|
Vero Cells | 1 | 2007 | 143 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2010 | 1008 | 0.070 |
Why?
|
Prognosis | 2 | 2021 | 21713 | 0.070 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2021 | 204 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1130 | 0.070 |
Why?
|
Genes, Viral | 1 | 2006 | 202 | 0.070 |
Why?
|
Survival Analysis | 1 | 2017 | 9180 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2012 | 1085 | 0.070 |
Why?
|
Interferon-gamma | 1 | 2010 | 1144 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 11538 | 0.070 |
Why?
|
Heart Ventricles | 2 | 2022 | 846 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2012 | 5637 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 1270 | 0.060 |
Why?
|
Luciferases | 1 | 2006 | 445 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 1823 | 0.060 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2008 | 612 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 6915 | 0.060 |
Why?
|
Blotting, Western | 1 | 2010 | 3536 | 0.060 |
Why?
|
Models, Biological | 1 | 2012 | 3254 | 0.060 |
Why?
|
Morula | 1 | 2023 | 4 | 0.060 |
Why?
|
Macrophages | 1 | 2010 | 1304 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2010 | 3033 | 0.060 |
Why?
|
Gene Amplification | 1 | 2006 | 731 | 0.060 |
Why?
|
Kinetics | 1 | 2006 | 2049 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 3203 | 0.050 |
Why?
|
Toll-Like Receptor 4 | 1 | 2023 | 203 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2023 | 269 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2023 | 309 | 0.050 |
Why?
|
Bone Marrow | 1 | 2010 | 2358 | 0.050 |
Why?
|
Oligopeptides | 1 | 2004 | 429 | 0.050 |
Why?
|
Middle Aged | 4 | 2022 | 86204 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2013 | 3343 | 0.050 |
Why?
|
Apoptosis | 1 | 2015 | 7591 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2008 | 5395 | 0.050 |
Why?
|
Embryonic Development | 1 | 2023 | 306 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 1879 | 0.050 |
Why?
|
Patient-Specific Modeling | 1 | 2020 | 28 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2023 | 862 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 4053 | 0.040 |
Why?
|
Flecainide | 1 | 2019 | 27 | 0.040 |
Why?
|
Mitral Valve | 1 | 2021 | 271 | 0.040 |
Why?
|
History, 21st Century | 1 | 2021 | 441 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 202 | 0.040 |
Why?
|
Lymphocytes | 1 | 2023 | 1234 | 0.040 |
Why?
|
Antigens, CD | 1 | 2023 | 1385 | 0.040 |
Why?
|
Virus Replication | 2 | 2015 | 709 | 0.040 |
Why?
|
Transcription Factors | 1 | 2013 | 5270 | 0.040 |
Why?
|
History, 20th Century | 1 | 2021 | 574 | 0.040 |
Why?
|
Time Factors | 2 | 2012 | 12926 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5319 | 0.040 |
Why?
|
Escherichia coli | 1 | 2023 | 1203 | 0.040 |
Why?
|
Glioma | 1 | 2008 | 1963 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2012 | 2314 | 0.040 |
Why?
|
1-Carboxyglutamic Acid | 1 | 2015 | 4 | 0.030 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2015 | 22 | 0.030 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2015 | 69 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2015 | 207 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2015 | 164 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2015 | 84 | 0.030 |
Why?
|
Collagen Type I | 1 | 2015 | 204 | 0.030 |
Why?
|
Caspase 9 | 1 | 2015 | 189 | 0.030 |
Why?
|
Electrocardiography | 1 | 2019 | 1145 | 0.030 |
Why?
|
Prevalence | 1 | 2021 | 3260 | 0.030 |
Why?
|
Mice, Inbred mdx | 1 | 2012 | 44 | 0.030 |
Why?
|
Bone Density | 1 | 2015 | 476 | 0.030 |
Why?
|
Ovalbumin | 1 | 2012 | 254 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2012 | 86 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2015 | 1764 | 0.030 |
Why?
|
Antigens | 1 | 2012 | 292 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 1489 | 0.020 |
Why?
|
Kupffer Cells | 1 | 2011 | 42 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 4892 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2021 | 4320 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2015 | 1021 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 699 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2011 | 385 | 0.020 |
Why?
|
Drug Tolerance | 1 | 2011 | 114 | 0.020 |
Why?
|
Homeostasis | 1 | 2015 | 950 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2015 | 1294 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 582 | 0.020 |
Why?
|
Interferon beta-1a | 1 | 2008 | 21 | 0.020 |
Why?
|
Antibodies | 1 | 2012 | 838 | 0.020 |
Why?
|
Butyrates | 1 | 2008 | 57 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 657 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 3341 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 1586 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 2008 | 175 | 0.020 |
Why?
|
Valproic Acid | 1 | 2008 | 263 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 14289 | 0.020 |
Why?
|
Drug Synergism | 1 | 2008 | 1313 | 0.020 |
Why?
|
Up-Regulation | 1 | 2011 | 2450 | 0.020 |
Why?
|
Risk Factors | 1 | 2021 | 17523 | 0.020 |
Why?
|
Phenotype | 1 | 2015 | 6295 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 2315 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2008 | 2927 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 7222 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 8223 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 15179 | 0.010 |
Why?
|
Adult | 1 | 2021 | 77950 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2008 | 4849 | 0.010 |
Why?
|
Melanoma | 1 | 2008 | 5317 | 0.010 |
Why?
|